Bachem Holding Overview

  • Founded
  • 1971
Founded
  • Status
  • Public
  • Employees
  • 1,408
Employees
  • Stock Symbol
  • BANB
Stock Symbol
  • Investments
  • 4
  • Share Price
  • $301.90
  • (As of Thursday Closing)

Bachem Holding General Information

Description

Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients, as well as on the development of biochemical products for research purposes. The group markets its product under the Bachem and Clinalfa brands. The business of the firm can be seen booming across the market of Switzerland, USA, Austria, Great Britain, Germany and internationally and it generates revenue through the sale of the product.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Stock Exchange
SWX
Primary Office
  • Hauptstrasse 144
  • 4416 Bubendorf
  • Switzerland
+41 058 000 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bachem Holding Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$301.90 $303.86 $128.43 - $309.72 $4.22B 14M 16K $3.93

Bachem Holding Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 3,751,448 2,275,286 1,700,500 2,209,274
Revenue 364,631 315,701 288,678 265,715
EBITDA 103,791 86,116 79,872 70,679
Net Income 68,112 54,507 47,664 42,425
Total Assets 697,913 667,896 624,352 559,142
Total Debt 120,555 110,535 152,823 97,459
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bachem Holding Executive Team (6)

Name Title Board Seat Contact Info
Thomas Früh Chief Executive Officer
Stephan Schindler Chief Financial Officer
Anne-Kathrin Stoller Chief Marketing Officer
You’re viewing 3 of 6 executive team members. Get the full list »

Bachem Holding Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bachem Holding Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000000 26-Feb-2015 000000000000000000 Other Pharmaceuticals and Biotechnology 000000 00ü0
000000 0000000 13-Aug-2007 00000 00000 00 000.00 Biotechnology
00000 00000000000 18-Jun-2007 000000000 00000 00 Buildings and Property 0000000 0ü0000
Pevion Biotech 15-Jan-2002 Joint Venture Biotechnology
To view Bachem Holding’s complete investments and acquisitions history, request access »

Bachem Holding Subsidiaries (1)

Company Name Industry Location Founded
00000000 0000000 Other Pharmaceuticals and Biotechnology Sunnyvale, CA 0000
To view Bachem Holding’s complete subsidiaries history, request access »

Bachem Holding Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 0000000 13-Aug-2007 00000 00000 00 000.00 Completed
  • 4 buyers
Pevion Biotech 15-Jan-2002 Joint Venture Completed
  • 2 buyers
To view Bachem Holding’s complete exits history, request access »